scispace - formally typeset
R

Randal D. Goff

Researcher at University of Wisconsin-Madison

Publications -  19
Citations -  1969

Randal D. Goff is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Natural killer T cell & CD1D. The author has an hindex of 12, co-authored 19 publications receiving 1891 citations. Previous affiliations of Randal D. Goff include Wisconsin Alumni Research Foundation & Brigham Young University.

Papers
More filters
Journal ArticleDOI

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

TL;DR: Evidence is reported for microbial, antigen-specific activation of NKT cells against Gram-negative, lipopolysaccharide (LPS)-negative alpha-Proteobacteria such as Ehrlichia muris and Sphingomonas capsulata and shows that glycosylceramides are an alternative to LPS for innate recognition of the Gram- negative, LPS-negative bacterial cell wall.
Journal ArticleDOI

Effects of Lipid Chain Lengths in α-Galactosylceramides on Cytokine Release by Natural Killer T Cells

TL;DR: It is found that truncation of the phytosphingosine lipid chain increases the relative amounts of immunomodulatory cytokines released, and the length of the acyl chain in alpha-galactosylceramides influences cytokine release profiles.
Journal ArticleDOI

Probing the Aglycon Promiscuity of an Engineered Glycosyltransferase

TL;DR: This study highlights the ability of OleD variants to glucosylate a total of 71 diverse acceptors, catalyze iterative glycosylation with numerous substrates, and establishes OleD as the first multifunctional GT capable of generating O-, S- and N-glycosides.
Journal ArticleDOI

Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides.

TL;DR: To facilitate the elucidation of the structural features of glycolipids necessary for T cell stimulation, α-galactosylceramides have been prepared with small molecules appended at the C6 position of the sugar.
Journal ArticleDOI

Optimizing Glycosyltransferase Specificity via “Hot Spot” Saturation Mutagenesis Presents a Catalyst for Novobiocin Glycorandomization

TL;DR: A comprehensive two-phase "hot spot" saturation mutagenesis strategy for the rapid evolution of glycosyltransferase (GT) specificity for nonnatural acceptors is described, which rapidly led to improvements in the desired catalytic activity of several hundred-fold.